INCREASED URINARY FREE CORTISOL AND DECREASED SERUM CORTICOSTEROID-BINDING GLOBULIN IN POLYCYSTIC-OVARY-SYNDROME

被引:21
作者
INVITTI, C
GIRALDI, FP
DUBINI, A
DEMARTIN, M
CAVAGNINI, F
机构
[1] CTR AUXOLOG ITALIANO,CHAIR ENDOCRINOL 2,CORSO MAGENTA 96,I-20121 MILAN,ITALY
[2] UNIV MILAN,MED CLIN 1,I-20122 MILAN,ITALY
[3] UNIV MILAN,CHAIR ENDOCRINOL 2,I-20122 MILAN,ITALY
来源
ACTA ENDOCRINOLOGICA | 1991年 / 125卷 / 01期
关键词
D O I
10.1530/acta.0.1250028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The adrenal participation in the pathogenesis of polycystic ovary syndrome is still under debate. In order to reappraise androgen and glucocorticoid secretion in this disease, we measured serum androstenedione, dehydroepiandrosterone-sulphate, total and free testosterone, sex hormone-binding globulin, LH, FSH, PRL, cortisol, corticosteroid-binding globulin, and urinary free cortisol in 45 women with polycystic ovary syndrome and 27 controls, subdivided in obese and normal-weight subjects. Androstenedione, total and free testosterone were significantly increased, whereas sex hormone-binding globulin tended to be reduced in patients with polycystic ovary syndrome compared with controls, reaching a significant difference between obese patients and matched controls. Free testosterone and sex hormone-binding globulin were significantly increased and reduced, respectively, in obese compared with normal-weight patients. Urinary free cortisol and serum corticosteroid-binding globulin were significantly increased (p < 0.001) and decreased (p < 0.005), respectively. Urinary free cortisol exceeded the upper limit of the normal range in 50% of our patients. No appreciable differences were found in PRL and cortisol levels. Besides confirming a hyperandrogenic state, our findings point to an overactivity of the hypothalamic-pituitary-adrenal axis with subsequent diminution of corticosteroid-binding globulin in polycystic ovary syndrome. They also indicate that urinary free cortisol is not a reliable index in differentiating polycystic ovary syndrome from Cushing's disease.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 26 条
[1]   CIRCULATING LEVELS OF PLASMA ADRENOCORTICOTROPIN IN POLYCYSTIC OVARY DISEASE [J].
CHANG, RJ ;
MANDEL, FP ;
WOLFSEN, AR ;
JUDD, HL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (06) :1265-1267
[2]   ARGININE VASOPRESSIN SECRETION IN NON-OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME [J].
COIRO, V ;
VOLPI, R ;
CAPRETTI, L ;
BACCHIMODENA, A ;
CIGARINI, C ;
BIANCONI, L ;
ROSSI, G ;
GRAMELLINI, D ;
CHIODERA, P .
ACTA ENDOCRINOLOGICA, 1989, 121 (06) :784-790
[3]  
CONWAY GS, 1990, CLIN ENDOCRINOL, V33, P593
[4]   PLASMA PRO-OPIOMELANOCORTIN FRAGMENTS AND ADRENAL-STEROIDS FOLLOWING ADMINISTRATION OF METYRAPONE TO NORMAL AND HIRSUTE WOMEN [J].
CUNNINGHAM, SK ;
LOUGHLIN, T ;
BERTAGNA, X ;
GIRARD, F ;
MCKENNA, TJ .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (04) :247-253
[5]   ADRENAL ANDROGEN SECRETION AND DOPAMINERGIC ACTIVITY IN ANOREXIA-NERVOSA [J].
DEVESA, J ;
PEREZFERNANDEZ, R ;
BOKSER, L ;
GAUDIERO, GJ ;
LIMA, L ;
CASANUEVA, FF .
HORMONE AND METABOLIC RESEARCH, 1988, 20 (01) :57-60
[6]   EFFECTS TESTOSTERONE TREATMENT ON PLASMA PROTEINS AND AMINO ACIDS IN MEN [J].
DICKINSON, P ;
ZINNEMAN, HH ;
SWAIM, WR ;
DOE, RP ;
SEAL, US .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1969, 29 (06) :837-+
[7]  
FERRIMAN D, 1961, J CLIN ENDOCRINOLOGY, V21, P1140
[8]   POLYCYSTIC OVARY SYNDROME [J].
GINSBURG, J ;
HAVARD, CWH .
BRITISH MEDICAL JOURNAL, 1976, 2 (6038) :737-740
[9]   SCINTIGRAPHIC EVIDENCE OF ADRENAL-CORTICAL DYSFUNCTION IN THE POLYCYSTIC-OVARY-SYNDROME [J].
GROSS, MD ;
WORTSMAN, J ;
SHAPIRO, B ;
MEYERS, LC ;
WOODBURY, MC ;
AYERS, JWT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (01) :197-201
[10]   ACTH FUNCTION IN WOMEN WITH THE POLYCYSTIC OVARIAN SYNDROME [J].
HORROCKS, PM ;
KANDEEL, FR ;
LONDON, DR ;
BUTT, WR ;
LYNCH, SS ;
HOLDER, G ;
LOGANEDWARDS, R .
CLINICAL ENDOCRINOLOGY, 1983, 19 (02) :143-150